<DOC>
	<DOCNO>NCT01137188</DOCNO>
	<brief_summary>Controlled data show obesity risk factor psoriasis psoriasis severity correlate degree overweight . No controlled interventional study report effect weight loss psoriatic skin manifestation publish data case report conflict . Patients psoriasis demonstrate increase susceptibility atherosclerotic comorbidities arterial hypertension , coronary vascular disease , stroke , hyperlipidemia type II diabetes severe psoriasis increase risk early death . Lately role inflammation atherosclerotic process highlight link psoriasis atherosclerosis may explain concomitant systemic inflammation psoriasis . Similarly state low level inflammation see obesity macrophage adipocytes begin show overlap function gene expression . This lead increased migration macrophage adipose tissue increase secretion pro-inflammatory cytokine . In summary , data theoretical consideration suggest weight loss obese patient psoriasis may improve skin manifestation reduce risk atherosclerotic comorbidity .</brief_summary>
	<brief_title>Effect Weight Loss Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>moderate/severe psoriasis inclusion previous systemic immunosuppressive therapy BMI &gt; 27 pregnancy/breast feeding diabetes require insulin treatment severe heart/kidney/liver disease gout high potassium intake obesity due medical conditions/medications use medical treatment obesity previous bariatric surgery intentional/unintentional weight loss 3 month prior inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>